Three new copper (II) complexes formulated as [Cu (L)(X)], where X= H 2 O or Cl and H 2 L
is a Schiff base (H 2 L 1, 2) or its reduced version (H 3 L 3 Cl) derived from pyridoxal, are …

A series of copper (II) complexes of Schiff base-derived ligands (1–7) were studied for their
pro-and antioxidant behaviour in the MCF-7 human breast cancer cell line. The coordination …

Copper (II) complexes have been intensely investigated in a variety of diseases and
pathological conditions due to their therapeutic potential. The development of these …

Since the discovery of cisplatin there has been a continuous pursuit for new metallodrugs
showing higher efficacies and lower side effects. In this work, new copper (II) complexes (C1 …

The cytotoxic properties of copper (II) complexes with 1, 10-phenanthroline (phen) can be
modified by substitution in the phen backbone. For this purpose, Cu (II) complexes with …

The reactions of copper chloride and 4′-(4′-substituted-phenyl)-2, 2′: 6′, 2′′-
terpyridine ligands bearing nitro (L1), methyl (L2), phenyl (L3), tolyl (L4) and carboxyl (L5) …

The interest in the use of copper as a metal scaffold for the development of novel
chemotherapeutics has considerably grown in recent years. This is mainly due to the …

Copper is an endogenous metal ion that has been studied to prepare a new antitumoral
agent with less side-effects. Copper is involved as a cofactor in several enzymes, in ROS …

Two new mixed ligand complexes of copper (II) containing an imidazolyl terpyridine
ligand,[Cu (Itpy)(bpy)](ClO4) 2·(H2O), 1, and [Cu (Itpy)(phen)(ClO4)](ClO4)·(H2O), 2 have …

Two new copper (II) complexes, Cu [(L) 2 (X)](1) and Cu [(L)(X) 2](2) where L= 1, 10-
phenanthroline and X=(2-pyrimidylthio)-acetic acid (PTAA), have been synthesized and …